We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
- Authors
Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A.; Arteaga, Carlos L.; Yang, Ximing J.; Wagner, Lynne I.; Cella, David; Meropol, Neal J.; Alpaugh, R. Katherine; Saphner, Thomas J.; Swaney, Robert E.; Hoelzer, Karen L.; Gradishar, William J.; Abramson, Vandana G.; Sundaram, P. Kothai; Jilani, Shamim Z.; Perez, Edith A.; Lin, Nancy U.; Jahanzeb, Mohammad; Wolff, Antonio C.
- Publication
Breast Cancer Research & Treatment, 2024, Vol 207, Issue 2, p275
- ISSN
0167-6806
- Publication type
Article
- DOI
10.1007/s10549-024-07417-4